Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma. (15th February 2015)

Record Type:: Journal Article
Title:: Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma. (15th February 2015)
Main Title:: Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma
Authors:: Viganò, M.
Grossi, G.
Borsotti, E.
Cappelletti, M.
Goldaniga, M.
Farina, L.
Rumi, M.
Corradini, P.
Baldini, L.
Colombo, M.
Lampertico, P.
Abstract:
Is Part Of:: Digestive and liver disease. Volume 47(2015)Supplement 1
Journal:: Digestive and liver disease
Issue:: Volume 47(2015)Supplement 1
Issue Display:: Volume 47, Issue 1 (2015)
Year:: 2015
Volume:: 47
Issue:: 1
Issue Sort Value:: 2015-0047-0001-0000
Page Start:: e62
Page End:
Publication Date:: 2015-02-15
Subjects:: Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:: http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.dld.2015.01.135 ↗
Languages:: English
ISSNs:: 1590-8658
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 5435.xml